French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa – Labiotech.eu (blog)
Labiotech.eu (blog) |
French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa
Labiotech.eu (blog) Horama has raised a second fundraising round that will support its lead candidate, a gene therapy for retinitis pigmentosa, through clinical trials. The French company Horama has announced the closing of its Series B round, which has ammassed a total … |
